2024

1. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

   The Lancet Neurology, Vol. 23, Núm. 8, pp. 775-786

2. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

   The Lancet, Vol. 403, Núm. 10444, pp. 2597-2605